Finding 574129 (2024-002)

Material Weakness Repeat Finding
Requirement
N
Questioned Costs
-
Year
2024
Accepted
2025-08-21
Audit: 364705
Organization: Legacy Medical Care Inc. (IL)

AI Summary

  • Core Issue: Legacy misapplied the sliding fee discount schedule, affecting patient charges based on their ability to pay.
  • Impacted Requirements: Compliance with federal regulations requiring accurate fee adjustments for eligible patients (42 USC 254 and 42 CFR sections).
  • Recommended Follow-Up: Increase self-reviews of patient encounters and enhance training for front desk staff on patient information collection and verification.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Grants for New and Expanded Services Under the Health Center Program Assistance Listing Number: 93.224/93.527 Federal Award Identification Number: L2C42352-01-00 Award Periods: July 1, 2021 – June 30, 2023; Type of Finding: Material noncompliance and Material weakness in internal control over compliance Criteria: Health centers must prepare and apply a sliding fee discount schedule so that the amounts owed for health center services by eligible patients are adjusted (discounted) based on the patient’s ability to pay. (42 USC 254(k)(3)(E), (F), and (G); 42 CFR sections 51c.303(e), (f), and (g); and 42 CFR sections 56.303(e), (f), and (g)). Condition: Legacy incorrectly assessed and/or applied the sliding fee discount to patient encounters during the year. Questioned Costs: None. Context: Five (5) of sixty (60) encounters selected for testing. Cause: Unknown. Effect: Patients are not charged according to Legacy's sliding fee scale and their ability to pay. Repeat Finding: Yes. Prior Year Finding: 2023-002. Recommendation: Management should consider increasing the frequency of its self-reviews of patient encounters or expanding its sample sizes in addition to providing additional training for front desk staff regarding the collection and verification of patient information for each patient. Views of Responsible Officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: •LMC will increase the frequency and sample size of its review of patient encounters. •LMC will be providing additional training for front desk staff regarding the collection and verification of patient information. Name(s) of the contact person(s) responsible for corrective action: Melissa D’Onorio, CEO, and Donna Landy, CFO. Planned completion date for corrective action plan: 08/15/2025

Categories

Material Weakness Internal Control / Segregation of Duties

Other Findings in this Audit

  • 574130 2024-003
    Material Weakness Repeat
  • 574131 2024-004
    Material Weakness
  • 574132 2024-005
    Significant Deficiency
  • 574133 2024-003
    Material Weakness Repeat
  • 574134 2024-005
    Significant Deficiency
  • 1150571 2024-002
    Material Weakness Repeat
  • 1150572 2024-003
    Material Weakness Repeat
  • 1150573 2024-004
    Material Weakness
  • 1150574 2024-005
    Significant Deficiency
  • 1150575 2024-003
    Material Weakness Repeat
  • 1150576 2024-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
21.027 Coronavirus State and Local Fiscal Recovery Funds $294,199
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $85,710
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $37,364
93.322 Cdc Partnership: Strengthening Public Health Laboratories $33,792
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated Exchanges $18,289
93.268 Immunization Cooperative Agreements $14,950
93.527 Grants for New and Expanded Services Under the Health Center Program $8,823